Finance

Lists
Why is 3378 down 3,02%?
Dive Deeper
3378:HKG
Hanx Biopharmaceuticals (Wuhan) Co Ltd
27,02 HK$
-3,02%
(-0,84) 1D
16 հոկ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3378...
Open
27,92 HK$
High
27,98 HK$
Low
27,02 HK$
Mkt. cap
3,62 մլրդ
Avg. vol.
8,22 հզր
Volume
3,70 հզր
52-wk high
33,80 HK$
52-wk low
13,48 HK$
Shares outstanding
136,22 մլն
No. of employees
60
Open
27,92 HK$
High
27,98 HK$
Low
27,02 HK$
Mkt. cap
3,62 մլրդ
Avg. vol.
8,22 հզր
Volume
3,70 հզր
52-wk high
33,80 HK$
52-wk low
13,48 HK$
Shares outstanding
136,22 մլն
No. of employees
60
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
16 րոպե առաջ
What Viasat Doubters Got Wrong
About Hanx Biopharmaceuticals (Wuhan) Co Ltd
CEO-
Employees60
Founded2014
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. մրտ
2025 թ. հնս
2026 թ. մրտ
2026 թ. հնս
Revenue
12,50 հզր
12,50 հզր
3,00 հզր
3,00 հզր
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,66 մլն
15,66 մլն
13,05 մլն
13,05 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,03 մլն
13,03 մլն
13,96 մլն
13,96 մլն
Operating expense
28,66 մլն
28,66 մլն
26,82 մլն
26,82 մլն
Total operating expenses
28,66 մլն
28,66 մլն
26,82 մլն
26,82 մլն
Operating income
-28,65 մլն
-28,65 մլն
-26,81 մլն
-26,81 մլն
Other non operating income
-190,50 հզր
-190,50 հզր
-8,75 մլն
-8,75 մլն
EBT including unusual items
-29,00 մլն
-29,00 մլն
-22,47 մլն
-22,47 մլն
EBT excluding unusual items
-31,44 մլն
-31,44 մլն
-33,05 մլն
-33,05 մլն
Income tax expense
-12,17 մլն
-12,17 մլն
-5,85 մլն
-5,85 մլն
Effective tax rate
41,97%
41,97%
26,02%
26,02%
Other operating expenses
-24,50 հզր
-24,50 հզր
-191,00 հզր
-191,00 հզր
Net income
-18,22 մլն
-18,22 մլն
-18,44 մլն
-18,44 մլն
Net profit margin
-145 760,00%
-145 760,00%
-614 716,67%
-614 716,67%
Earnings per share
-
-
-
-
Interest and investment income
163,50 հզր
163,50 հզր
3,03 մլն
3,03 մլն
Interest expense
-2,77 մլն
-2,77 մլն
-519,50 հզր
-519,50 հզր
Net interest expenses
-2,60 մլն
-2,60 մլն
2,51 մլն
2,51 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,15 մլն
-28,15 մլն
-26,09 մլն
-26,09 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps